DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Thursday reported a loss of $12 million in its second quarter.
On a per-share basis, the Devon, Pennsylvania-based company said it had a loss of 89 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 77 cents per share.
Zynerba shares have decreased 49 percent since the beginning of the year. The stock has fallen 57 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZYNE at https://www.zacks.com/ap/ZYNE